![Kenichiro Nakamura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenichiro Nakamura
Direktor/Vorstandsmitglied bei
Summit Pharmaceuticals China Ltd.
Vermögen: 560 965 $ am 31.05.2026
Profil
Kenichiro Nakamura was the founder of Shanon, Inc. (2000) and held the title of President & Representative Director.
Current jobs include Director at Summit Pharmaceuticals International Corp., Director at Summit Pharmaceuticals Europe Ltd., Director at Summit Pharmaceuticals China Ltd., and Auditor at Appexchange Consortium since 2017.
Former jobs include Non-Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd. and Director at Presperse Corp.
Education includes an undergraduate degree from Keio University, conferred in 2001.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SHANON, INC. 3,01 % | 06.02.2026 | 178.600 ( 3,01 % ) | 560 965 $ | 31.05.2026 |
Aktive Positionen von Kenichiro Nakamura
| Unternehmen | Position | Beginn |
|---|---|---|
Summit Pharmaceuticals China Ltd.
 Summit Pharmaceuticals China Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Summit Pharmaceuticals International Corp.
 Summit Pharmaceuticals International Corp. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and other consulting services to Japanese pharmaceutical companies | Direktor/Vorstandsmitglied | - |
Appexchange Consortium | Comptroller/Controller/Auditor | 01.05.2017 |
Ehemalige bekannte Positionen von Kenichiro Nakamura
| Unternehmen | Position | Ende |
|---|---|---|
Summit Pharmaceuticals Europe Ltd.
 Summit Pharmaceuticals Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Markets pharmaceutical intermediates and raw materials | Direktor/Vorstandsmitglied | - |
| SHANON INC. | Gründer | - |
Presperse Corp.
 Presperse Corp. Specialty StoresRetail Trade Provides cosmetic and personal care products | Direktor/Vorstandsmitglied | - |
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ausbildung von Kenichiro Nakamura
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Summit Pharmaceuticals International Corp.
Summit Pharmaceuticals International Corp. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and other consulting services to Japanese pharmaceutical companies | Commercial Services |
Keio University
 Keio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presperse Corp.
Presperse Corp. Specialty StoresRetail Trade Provides cosmetic and personal care products | Retail Trade |
Summit Pharmaceuticals Europe Ltd.
Summit Pharmaceuticals Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Markets pharmaceutical intermediates and raw materials | Commercial Services |
Shanon, Inc.
 Shanon, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company which provides consulting and outsourcing services related to marketing | Commercial Services |
Summit Pharmaceuticals China Ltd.
Summit Pharmaceuticals China Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Appexchange Consortium |
Wählen Sie MarketScreener 
